{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=27", "query": { "intervention": "Control Study Product", "page": 27 }, "page_size": 10 }, "pagination": { "page": 27, "page_size": 10, "total_count": 4231, "total_pages": 424, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=28&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=26&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T07:32:25.403Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05309200", "title": "A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cirrhosis", "Ascites", "Hepatorenal Syndrome", "Acute Kidney Injury" ], "interventions": [ { "name": "OCE-205", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ocelot Bio, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 47, "start_date": "2022-04-28", "completion_date": "2023-10-13", "has_results": false, "last_update_posted_date": "2023-12-15", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 22, "location_summary": "Phoenix, Arizona • Los Angeles, California • San Francisco, California + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05309200" }, { "nct_id": "NCT05560477", "title": "Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Meniscus Tear" ], "interventions": [ { "name": "AM3101", "type": "DRUG" }, { "name": "Saline Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 22, "start_date": "2023-04-26", "completion_date": "2026-09-30", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 3, "location_summary": "Cincinnati, Ohio • Cleveland, Ohio • Portland, Oregon", "locations": [ { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT05560477" }, { "nct_id": "NCT00461812", "title": "A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Mometasone", "type": "DRUG" }, { "name": "Advair", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 33, "start_date": "2007-04", "completion_date": "2010-01-19", "has_results": true, "last_update_posted_date": "2017-09-20", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00461812" }, { "nct_id": "NCT00689819", "title": "Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension", "High Blood Pressure", "Ventricular Hypertrophy", "Diastolic Dysfunction", "Systolic Dysfunction" ], "interventions": [ { "name": "Exercise", "type": "BEHAVIORAL" }, { "name": "Weight Loss", "type": "BEHAVIORAL" }, { "name": "Low Sodium Diet", "type": "BEHAVIORAL" }, { "name": "Smoking Cessation", "type": "BEHAVIORAL" }, { "name": "Pharmaceutical Therapy (no specific therapy; approach guided by the JNC 7 protocol guidelines)", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "Wayne State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "35 Years to 75 Years" }, "enrollment_count": 123, "start_date": "2008-10", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2013-12-03", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00689819" }, { "nct_id": "NCT05766267", "title": "Short-course Regimens for the Treatment of Pulmonary Tuberculosis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Tuberculosis, Pulmonary", "Tuberculosis Infection" ], "interventions": [ { "name": "Rifabutin", "type": "DRUG" }, { "name": "Delamanid", "type": "DRUG" }, { "name": "Bedaquiline", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Pyrazinamide", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Ethambutol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 288, "start_date": "2023-11-21", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05766267" }, { "nct_id": "NCT00854100", "title": "Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Antidepressant + placebo", "type": "DRUG" }, { "name": "Antidepressant + cariprazine (0.1-0.3 mg/day)", "type": "DRUG" }, { "name": "Antidepressant + cariprazine (1-2 mg/d)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 231, "start_date": "2009-06-30", "completion_date": "2010-12-06", "has_results": true, "last_update_posted_date": "2019-03-05", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 41, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Arcadia, California + 35 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00854100" }, { "nct_id": "NCT02066571", "title": "Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinson's Disease", "Freezing of Gait", "Cognitive Ability, General" ], "interventions": [ { "name": "Droxidopa", "type": "DRUG" }, { "name": "sugar pill", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 20, "start_date": "2015-03", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2016-11-03", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 2, "location_summary": "Chicago, Illinois • West Bloomfield, Michigan", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "West Bloomfield", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02066571" }, { "nct_id": "NCT00515177", "title": "Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Chronic Insomnia", "Primary Insomnia" ], "interventions": [ { "name": "Mindfulness-Based Stress Reduction", "type": "BEHAVIORAL" }, { "name": "eszopiclone", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 30, "start_date": "2007-08", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2013-03-29", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00515177" }, { "nct_id": "NCT00829777", "title": "Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Opiate Addiction" ], "interventions": [ { "name": "6β-Naltrexol escalating doses from 0.05-0.5 mg IV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "California Pacific Medical Center Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "21 Years to 45 Years" }, "enrollment_count": 8, "start_date": "2009-03", "completion_date": "2009-09", "has_results": false, "last_update_posted_date": "2009-09-16", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00829777" }, { "nct_id": "NCT04553406", "title": "Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mycobacterium Avium Complex", "Non-tuberculous Mycobacterium Pulmonary Disease" ], "interventions": [ { "name": "SPR720", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Open-label Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Spero Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2020-12-03", "completion_date": "2021-01-28", "has_results": true, "last_update_posted_date": "2022-02-28", "last_synced_at": "2026-10-22T07:32:25.403Z", "location_count": 9, "location_summary": "Altamonte Springs, Florida • Atlantis, Florida • Clearwater, Florida + 6 more", "locations": [ { "city": "Altamonte Springs", "state": "Florida" }, { "city": "Atlantis", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04553406" } ] }